These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 16794930

  • 1. Optimal control in a model of dendritic cell transfection cancer immunotherapy.
    Castiglione F, Piccoli B.
    Bull Math Biol; 2006 Feb; 68(2):255-74. PubMed ID: 16794930
    [Abstract] [Full Text] [Related]

  • 2. Cancer immunotherapy, mathematical modeling and optimal control.
    Castiglione F, Piccoli B.
    J Theor Biol; 2007 Aug 21; 247(4):723-32. PubMed ID: 17543345
    [Abstract] [Full Text] [Related]

  • 3. Generation of dendritic cell-based vaccines for cancer therapy.
    Reinhard G, Märten A, Kiske SM, Feil F, Bieber T, Schmidt-Wolf IG.
    Br J Cancer; 2002 May 20; 86(10):1529-33. PubMed ID: 12085199
    [Abstract] [Full Text] [Related]

  • 4. Immunotherapy with dendritic cells for cancer.
    Ballestrero A, Boy D, Moran E, Cirmena G, Brossart P, Nencioni A.
    Adv Drug Deliv Rev; 2008 Jan 14; 60(2):173-83. PubMed ID: 17977615
    [Abstract] [Full Text] [Related]

  • 5. Genetically modified dendritic cell-based cancer vaccines.
    Bubeník J.
    Folia Biol (Praha); 2001 Jan 14; 47(5):153-5. PubMed ID: 11686430
    [No Abstract] [Full Text] [Related]

  • 6. Exploiting dendritic cells for active immunotherapy of cancer and chronic infection.
    O'Neill D, Bhardwaj N.
    Methods Mol Med; 2005 Jan 14; 109():1-18. PubMed ID: 15585909
    [Abstract] [Full Text] [Related]

  • 7. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H, Shurin MR, Han B.
    Expert Rev Vaccines; 2007 Jun 14; 6(3):333-45. PubMed ID: 17542749
    [Abstract] [Full Text] [Related]

  • 8. [Dendritic cell-based cancer immunotherapy].
    Aruga A.
    Nihon Rinsho; 2010 Jun 14; 68(6):1107-10. PubMed ID: 20535963
    [Abstract] [Full Text] [Related]

  • 9. [Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer].
    Punt CJ, de Vries IJ, Mulders PF, Adema GJ, Figdor CG.
    Ned Tijdschr Geneeskd; 1999 Nov 27; 143(48):2408-14. PubMed ID: 10608974
    [Abstract] [Full Text] [Related]

  • 10. On immunotherapies and cancer vaccination protocols: a mathematical modelling approach.
    Joshi B, Wang X, Banerjee S, Tian H, Matzavinos A, Chaplain MA.
    J Theor Biol; 2009 Aug 21; 259(4):820-7. PubMed ID: 19446568
    [Abstract] [Full Text] [Related]

  • 11. [Dendritic cells--strong candidates for immunotherapy].
    Lund-Johansen F, Olweus J.
    Tidsskr Nor Laegeforen; 1999 Jun 30; 119(17):2510-4. PubMed ID: 10425906
    [Abstract] [Full Text] [Related]

  • 12. Dendritic cell vaccines for leukemia patients.
    Schmitt A, Hus I, Schmitt M.
    Expert Rev Anticancer Ther; 2007 Mar 30; 7(3):275-83. PubMed ID: 17338648
    [Abstract] [Full Text] [Related]

  • 13. Viral vectors for gene transfer into antigen presenting cells.
    Monahan SJ, Salgaller ML.
    Curr Opin Mol Ther; 1999 Oct 30; 1(5):558-64. PubMed ID: 11249662
    [Abstract] [Full Text] [Related]

  • 14. Priming anticancer active specific immunotherapy with dendritic cells.
    Mocellin S.
    Curr Opin Investig Drugs; 2005 Jun 30; 6(6):576-81. PubMed ID: 15988908
    [Abstract] [Full Text] [Related]

  • 15. Immunotherapy of cancer using dendritic cells.
    Morse MA, Lyerly HK.
    Cytokines Cell Mol Ther; 1998 Mar 30; 4(1):35-44. PubMed ID: 9557215
    [Abstract] [Full Text] [Related]

  • 16. Dendritic cells as therapeutic vaccines against cancer.
    Banchereau J, Palucka AK.
    Nat Rev Immunol; 2005 Apr 30; 5(4):296-306. PubMed ID: 15803149
    [Abstract] [Full Text] [Related]

  • 17. Current issues in delivering DCs for immunotherapy.
    Barratt-Boyes SM, Figdor CG.
    Cytotherapy; 2004 Apr 30; 6(2):105-10. PubMed ID: 15203986
    [Abstract] [Full Text] [Related]

  • 18. Vaccination for treatment and prevention of cancer in animal models.
    Cavallo F, Offringa R, van der Burg SH, Forni G, Melief CJ.
    Adv Immunol; 2006 Apr 30; 90():175-213. PubMed ID: 16730264
    [Abstract] [Full Text] [Related]

  • 19. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.
    Yannelli JR, Wroblewski JM.
    Vaccine; 2004 Nov 15; 23(1):97-113. PubMed ID: 15519713
    [Abstract] [Full Text] [Related]

  • 20. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
    Shojaeian J, Jeddi-Tehrani M, Dokouhaki P, Mahmoudi AR, Ghods R, Bozorgmehr M, Nikoo S, Bayat AA, Akhondi MM, Ostadkarampour M, Rezania S, Zarnani AH.
    J Immunother; 2009 May 15; 32(4):325-32. PubMed ID: 19342973
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.